Douglas Fink
- Co-authors
- Nina GoldmanZoe DaviesF MartínGreg J. TowersRebecca P. SumnerRobert F. MillerB D WeintraubNeil Gesundheit
- Topics
- HIV Research and Treatment (4 papers)interferon and immune responses (3 papers)COVID-19 Clinical Research Studies (2 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Douglas Fink
29 papers receiving 305 citations
Peers
Comparison fields: 5 of 80
- Infectious Diseases 102
- Epidemiology 63
- Immunology 61
- Virology 58
- Genetics 48
Countries citing papers authored by Douglas Fink
This map shows the geographic impact of Douglas Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fink more than expected).
Fields of papers citing papers by Douglas Fink
This network shows the impact of papers produced by Douglas Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fink. The network helps show where Douglas Fink may publish in the future.
Co-authorship network of co-authors of Douglas Fink
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Fink. A scholar is included among the top collaborators of Douglas Fink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Fink. Douglas Fink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 11 | |
| 3 | 9 | |
| 4 | ROX Index to Guide Management of COVID-19 Pneumonia | 1 |
| 5 | 57 | |
| 6 | 39 | |
| 7 | 10 | |
| 8 | 3 | |
| 9 | 5 | |
| 10 | 11 | |
| 11 | 8 | |
| 12 | 20 | |
| 13 | 6 | |
| 14 | 13 | |
| 15 | 1 | |
| 16 | 7 | |
| 17 | 0 | |
| 18 | 1 | |
| 19 | 1 | |
| 20 | 8 |
About Douglas Fink
Douglas Fink is a scholar working on Virology, Family Practice and Infectious Diseases, having authored 31 papers that have together received 331 indexed citations. Recurring topics across this work include HIV Research and Treatment (4 papers), interferon and immune responses (3 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Virology (58 citations), Infectious Diseases (102 citations) and Immunology (61 citations). Douglas Fink has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Nina Goldman, Zoe Davies, F Martín, Greg J. Towers, Rebecca P. Sumner, Robert F. Miller, B D Weintraub, Neil Gesundheit, Michael J. Malloy and Lucy Thorne. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and PEDIATRICS.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.